Based on these studies, inhibition of TDP‐43 phosphorylation by specific kinase inhibitors has even been proposed as a potential therapeutic strategy for ALS (Liachko et al, 2013; Salado et al, 2014; Martinez‐Gonzalez et al, 2020). The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.